These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical and biochemical predictors affect the choice and the short-term outcomes of different thrombolytic agents in acute myocardial infarction. El-Menyar AA, Altamimi OM, Gomaa MM, Dabdoob W, Abbas AA, Abdel Rahman MO, Bener A, Albinali HA. Coron Artery Dis; 2006 Aug; 17(5):431-7. PubMed ID: 16845251 [Abstract] [Full Text] [Related]
9. Terminal QRS distortion on admission is better than ST-segment measurements in predicting final infarct size and assessing the Potential effect of thrombolytic therapy in anterior wall acute myocardial infarction. Birnbaum Y, Maynard C, Wolfe S, Mager A, Strasberg B, Rechavia E, Gates K, Wagner GS. Am J Cardiol; 1999 Sep 01; 84(5):530-4. PubMed ID: 10482150 [Abstract] [Full Text] [Related]
18. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W, Schmutzler H. Herz; 1994 Dec 01; 19(6):336-52. PubMed ID: 7843690 [Abstract] [Full Text] [Related]
19. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW. J Am Coll Cardiol; 1995 Jun 01; 25(7):1552-7. PubMed ID: 7759706 [Abstract] [Full Text] [Related]